POTENZA Therapeutics

Potenza Therapeutics is a preclinical stage biotechnology company based in Cambridge, Massachusetts. Led by a team of experienced researchers and scientists, the company employs 14 people and has generated $3 million in revenue. Potenza Therapeutics specializes in the development of innovative cancer immunotherapy treatments. Their research focuses on harnessing the power of the body's own immune system to fight cancer cells. While their therapies are still in the preclinical stage, they hold significant promise for improving cancer treatment options in the future. The company's commitment to cutting-edge research and development is at the heart of its mission. Potenza Therapeutics leverages advanced scientific techniques and a deep understanding of the complexities of the immune system to create novel and effective cancer therapies. For more information about Potenza Therapeutics and their groundbreaking work, visit their website at potenzatherapeutics.com.